first glp 1 approved for weight loss GLP-1 Agonists: A Comprehensive Overview A big win for Wegovy:

13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura

This extra water might also cause bloating, a puffier appearance, and mild digestive complaints like cramps or diarrhea, particularly when large doses are taken or during the loading phase

Front Cell Dev Biol 10:950623

Bone marrow contribution to synovial hyperplasia following joint surface injury

Before starting GLP-1 therapy, we recommend optimizing your thyroid function